Tenders Are Invited For Somatropin (Recombinant Human Growth Hormone, Rhgh)

Tenders are invited for Somatropin (Recombinant Human Growth Hormone, rHGH). Somatropin (Recombinant Human Growth Hormone, rHGH) or its approved biosimilar vial or pen. Each 1.33 mg dose = 4 units, regardless of the total volume of the vial or pen. 1233 Cinnatropin 5 mg/1.5 ml and Cinnatropin 10 mg/1.5 ml are approved as biosimilars of the reference substance, Genotropin. The study will be conducted over a period of six months and limited to a number of patients (20-30) at the Child Protection Hospital in the Medical City Department. We will be provided with the study results before contracting. In the event of referral and preparation of the first dose, 1232 1161 The quantity is calculated based on the patients weight and daily dose. Institutions responsible for dispensing the substance are required to attach the patients health records, names, and weights when calculating the need. This is based on the general need. 2018 AD 986 started with the above 1031 Payment of a non refundable fee with lump sum as follows: a- (1.000.000)one million Iraqi Dinar of the tender that less than (1.000.000) Dollars . b- (2.000.000)two million Iraqi Dinar for the tender that more than (1.000.000) Dinar. A intial garantees Security at ratio 1% Tender Link : https://kimadia.gov.iq/en/category/medicines/